Related Experiment Video

Updated: Jun 20, 2026

Generation of Fluorescent Protein Fusions in Candida Species
09:27

Generation of Fluorescent Protein Fusions in Candida Species

Published on: March 4, 2017

The use of fluconazole in neonatal intensive care units

P Manzoni1, M Mostert, E Jacqz-Aigrain

  • 1Neonatology and NICU, S Anna Hospital. Azienda Ospedaliera Regina Margherita, S Anna, C so Spezia 60, 10126 Torino, Italy. paolomanzoni@hotmail.com

Archives of Disease in Childhood
|September 3, 2009
PubMed

Insights

Preventing invasive fungal infections in premature infants is crucial. Fluconazole shows promise for high-risk neonates in NICU, though it

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Premature neonates in NICU face high risks of invasive fungal infections (IFI), primarily Candida species.
  • IFI contributes significantly to morbidity, mortality, and neurodevelopmental issues in survivors.
  • IFI diagnosis is challenging due to transient candidemia and high rates of organ dissemination.

Purpose of the Study:

  • To review current evidence on fluconazole use for IFI prevention in preterm neonates.
  • To discuss the potential benefits and concerns of using fluconazole in NICU settings.

Main Methods:

  • Review of retrospective and prospective clinical trials on fluconazole prophylaxis.
  • Analysis of existing data on fluconazole efficacy and safety in preterm infants.

Main Results:

  • Fluconazole administration has demonstrated effectiveness in multiple studies for preventing IFI.
  • Four randomized, prospective clinical trials support fluconazole's efficacy.
  • Despite evidence, fluconazole is not yet standard care for high-risk preterm neonates.

Conclusions:

  • Preventing IFI is the most effective strategy to reduce disease burden in preterm neonates.
  • Fluconazole is a viable preventive option supported by clinical evidence.
  • Further discussion is needed regarding the implementation of fluconazole as standard care in NICU.

More Related Videos

Induction of Petite Colonies in Candida glabrate via Rose Bengal-Mediated Photodynamic Therapy09:06

Induction of Petite Colonies in Candida glabrate via Rose Bengal-Mediated Photodynamic Therapy

Published on: March 29, 2024

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...